Article Information
History
- April 13, 2021.
Article Versions
- Version 1 (January 5, 2021 - 11:33).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Elliot Akama-Garren1,+,
- Praveen Anand2,+,
- Tudor Cristea-Platon1,
- Patrick Lenehan1,
- Emily Lindemer1,
- Sairam Bade2,
- Saran Liukasemsarn1,
- John C. O’Horo3,
- Ryan T. Hurt3,
- Amy W. Williams3,
- Gregory J. Gores3,
- Andrew D. Badley3,
- Samir Awasthi1,* and
- Venky Soundararajan1,2,*
- 1nference, inc., One Main Street, Suite 400, East Arcade, Cambridge, MA 02142, USA
- 2nference Labs,2nd Floor, 22 3rd Cross Rd, Murgesh Pallya, Bengaluru, India
- 3Mayo Clinic, Rochester MN, USA
- ↵*Correspondence to: SA (samir{at}nference.net) and VS (venky{at}nference.net)
Posted April 13, 2021.
Hair loss in females and thromboembolism in males are significantly enriched in post-acute sequelae of COVID (PASC) relative to recent medical history
